Clonazepam in Juvenile Myoclonic Epilepsy
- 1 October 1989
- Vol. 30 (5), 603-606
- https://doi.org/10.1111/j.1528-1157.1989.tb05479.x
Abstract
We studied the efficacy of clonazepam (CZP) in control of juvenile myoclonic epilepsy (JME) in 17 patients. CZP was very effective in controlling myoclonic jerks in all patients but did not suppress generalized tonic-clonic seizures (GTCS). A disadvantage occurs because the patient is deprived of the warning jerks which presage the onset of GTCS. The circadian rhythm of the GTCS was also changed in two patients.This publication has 9 references indexed in Scilit:
- Absences in juvenile myoclonic epilepsy: A clinical and video‐electroencephalographic studyAnnals of Neurology, 1989
- Juvenile Myoclonic Epilepsy: A Study in Saudi ArabiaEpilepsia, 1988
- Juvenile myoclonic epilepsy of JanzNeurology, 1984
- Arsenic neuropathyNeurology, 1981
- Treatment of epilepsy with clonazepam and its effect on other anticonvulsants.Journal of Neurology, Neurosurgery & Psychiatry, 1977
- Clonazepam in the Treatment of Children with Intractable SeizuresDevelopmental Medicine and Child Neurology, 1977
- Treatment of Generalized Epilepsies of Childhood and Adolescence with Sodium Valproate (‘Epilim’)Developmental Medicine and Child Neurology, 1977
- ClonazepamDrugs, 1976
- ClonazepamArchives of Neurology, 1976